Exodus Point Capital Management, LP Arcturus Therapeutics Holdings Inc. Transaction History

Exodus Point Capital Management, LP

  • $16.4 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
BUY
$25.44 - $37.35 $47,343 - $69,508
1,861 Added 8.79%
23,037 $589,000
Q2 2023

Aug 10, 2023
SELL
$23.94 - $32.36 $215,172 - $290,851
-8,988 Reduced 29.8%
21,176 $607,000
Q1 2023

May 11, 2023
BUY
$14.72 - $23.97 $5,122 - $8,341
348 Added 1.17%
30,164 $723,000
Q4 2022

Feb 13, 2023
SELL
$14.14 - $23.06 $250,787 - $408,992
-17,736 Reduced 37.3%
29,816 $506,000
Q3 2022

Nov 10, 2022
BUY
$13.05 - $22.13 $620,553 - $1.05 Million
47,552 New
47,552 $705,000
Q4 2021

Feb 11, 2022
SELL
$34.2 - $47.56 $750,245 - $1.04 Million
-21,937 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$27.88 - $58.25 $611,603 - $1.28 Million
21,937 New
21,937 $1.05 Million
Q1 2021

May 17, 2021
SELL
$38.75 - $86.92 $902,952 - $2.03 Million
-23,302 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$34.61 - $123.66 $475,991 - $1.7 Million
-13,753 Reduced 37.12%
23,302 $1.01 Million
Q3 2020

Nov 16, 2020
BUY
$37.49 - $63.19 $1.39 Million - $2.34 Million
37,055 New
37,055 $1.59 Million
Q1 2020

May 15, 2020
SELL
$9.31 - $18.26 $103,666 - $203,325
-11,135 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$8.93 - $12.41 $99,435 - $138,185
11,135 New
11,135 $121,000

Others Institutions Holding ARCT

# of Institutions
179
Shares Held
25.6M
Call Options Held
195K
Put Options Held
133K
View Full List

About Arcturus Therapeutics Holdings Inc.

ARCT Quotes by TradingView
  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $411M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email